212 related articles for article (PubMed ID: 19131186)
21. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
22. Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Mocikova H; Pytlik R; Stepankova P; Michalka J; Markova J; Koren J; Buresova L; Raida L; Kral Z
Acta Haematol; 2015; 134(3):187-92. PubMed ID: 26021284
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody.
Decaudin D; Levy R; Lokiec F; Morschhauser F; Djeridane M; Kadouche J; Pecking A
Anticancer Drugs; 2007 Jul; 18(6):725-31. PubMed ID: 17762404
[TBL] [Abstract][Full Text] [Related]
24. Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.
Eich HT; Engenhart-Cabillic R; Hansemann K; Lukas P; Schneeweiss A; Seegenschmiedt H; Skripnitchenko R; Staar S; Willich N; Müller RP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1419-24. PubMed ID: 18234433
[TBL] [Abstract][Full Text] [Related]
25. Nodular lymphocyte predominance Hodgkin's disease: long-term observation reveals a continuous pattern of recurrence.
Orlandi E; Lazzarino M; Brusamolino E; Paulli M; Astori C; Magrini U; Bernasconi C
Leuk Lymphoma; 1997 Jul; 26(3-4):359-68. PubMed ID: 9322899
[TBL] [Abstract][Full Text] [Related]
26. Nodular lymphocyte predominant Hodgkin lymphoma.
Lee AI; LaCasce AS
Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
[TBL] [Abstract][Full Text] [Related]
27. Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.
Piccinno R; Caccialanza M; Percivalle S
J Dermatolog Treat; 2009; 20(3):165-8. PubMed ID: 18979277
[TBL] [Abstract][Full Text] [Related]
28. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
29. [Etiology of pericardial effusion following radiation therapy of Hodgkin's disease].
Kurtz B; Maisch B; Voss AC
Strahlentherapie; 1981 Sep; 157(9):571-5. PubMed ID: 7347436
[TBL] [Abstract][Full Text] [Related]
30. [Renal and ureter complications from the treatment of Hodgkin's disease].
Miltényi Z; Keresztes K; Váróczy L; Illés A
Magy Onkol; 2002; 46(4):351-5. PubMed ID: 12563359
[TBL] [Abstract][Full Text] [Related]
31. Clinical correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease.
Tefferi A; Zellers RA; Banks PM; Therneau TM; Colgan JP
J Clin Oncol; 1990 Dec; 8(12):1959-65. PubMed ID: 2230888
[TBL] [Abstract][Full Text] [Related]
32. [Radiation injuries in patients with lymphogranulomatosis in prolonged clinical remission].
Zolotkov AG; Pan'shin GA
Med Radiol (Mosk); 1986 Aug; 31(8):49-53. PubMed ID: 3747756
[TBL] [Abstract][Full Text] [Related]
33. A solitary conjunctival relapse of Hodgkin's disease treated by radiotherapy.
Kremer I; Loven D; Mor C; Lurie H
Ophthalmic Surg; 1989 Jul; 20(7):494-6. PubMed ID: 2779954
[TBL] [Abstract][Full Text] [Related]
34. Successful outcome of patients with relapsed/refractor Hodgkin lymphoma treated with high dose chemotherapy at the National Adult Bone Marrow Transplant Unit at St. James's Hospital.
Bacon CL; Daly P; Sheane B; Conneally EC; Browne PV; McCann S; Ni Chongaile M; O'Brian DS; Mc Dermott R; Hollywood D; Wilson L; Vandenberghe E
Ir Med J; 2009 Jan; 102(1):26-8. PubMed ID: 19284016
[TBL] [Abstract][Full Text] [Related]
35. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
36. Analysis of primary relapses after radiotherapy in Hodgkin's disease.
Spittle MF; Harmer CL; Cassady JR; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():497-508. PubMed ID: 4744605
[No Abstract] [Full Text] [Related]
37. Contribution of artificial intelligence to the knowledge of prognostic factors in Hodgkin's lymphoma.
Buciński A; Marszałł MP; Krysiński J; Lemieszek A; Załuski J
Eur J Cancer Prev; 2010 Jul; 19(4):308-12. PubMed ID: 20473182
[TBL] [Abstract][Full Text] [Related]
38. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
39. [Autologous stem cell transplantation in patients with relapsed or refractory Hodgkin's disease].
Minigo H; Vrhovac R; Kalac M; Jaksić B
Acta Med Croatica; 2009 Jun; 63(3):215-7. PubMed ID: 19827348
[TBL] [Abstract][Full Text] [Related]
40. [Lymphocyte response to phytohemagglutinin-stimulation after extended radiation therapy in Hodgkin's disease (author's transl)].
Krüsmann W; Slanina J; Vorwerck H
Strahlentherapie; 1979 Jun; 155(6):416-8. PubMed ID: 111376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
